Page last updated: 2024-12-05

2-fluoroaniline

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

2-fluoroaniline: structure given in first source; RN given refers to parent compound [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

2-fluoroaniline : A derivative of aniline in which the hydrogen at position 2 has been substituted by fluorine. It is used as a pharmaceutical intermediate [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID9584
CHEMBL ID195328
CHEBI ID27526
SCHEMBL ID33295
MeSH IDM0181759

Synonyms (60)

Synonym
2-fluoro-phenylamine
chebi:27526 ,
o-aminofluorobenzene
BIDD:GT0093
benzenamine, 2-fluoro-
nsc-10299
aniline, o-fluoro-
2-fluorobenzenamine
1-amino-2-fluorobenzene
nsc10299
1AN ,
inchi=1/c6h6fn/c7-5-3-1-2-4-6(5)8/h1-4h,8h
348-54-9
2-fluoroaniline
o-fluoroaniline
2-fluoroaniline, >=99%
1LGW
DB02403
AKOS000118879
bdbm50167958
2-fluorobenzenaminium
CHEMBL195328 ,
BMSE000724
F0032
STK802386
A6120
(2-fluorophenyl)-amine
2-fluoro-benzenamine
einecs 206-478-9
se32zk6617 ,
o-fluoroaniline [un2941] [keep away from food]
ai3-52644
nsc 10299
unii-se32zk6617
2-fluorophenylamine
FT-0612404
AM61468
CS-M2715
SCHEMBL33295
2-flouroaniline
2-fluoro aniline
2-fluoro-aniline
2-fluoroaniline-
2fluoroaniline
(2-fluorophenyl)amine
2-fluorobenzeneamine
ortho-fluoroaniline
DTXSID8059843
aniline, 2-fluoro-
un 2941
mfcd00007642
J-509510
F2190-0425
Q27093404
STR00771
CCG-302491
1,2-fluorobenzenamine
EN300-19550
PD008363
Z104474198

Research Excerpts

Toxicity

ExcerptReferenceRelevance
" The nephrotoxic and hepatotoxic potentials were similar among the 2-haloanilines but aniline was less toxic than its 2-halo derivatives."( Acute renal and hepatic toxicity of 2-haloanilines in Fischer 344 rats.
Anestis, DK; Ball, JG; Beers, KW; Hubbard, JL; Madan, E; Rankin, GO; Valentovic, MA, 1992
)
0.28

Dosage Studied

ExcerptRelevanceReference
" p-Hydroxymephentermine (p-hydroxy-MP) and p-hydroxyphentermine (p-hydroxy-Ph) were isolated as hydrochlorides from urine of male Wistar rats repeatedly dosed with mephentermine (MP)."( Isolation of urinary p-hydroxylated metabolites of mephentermine and phentermine in male Wistar rats.
Inoue, M; Kozuka, H; Miyahara, T; Mori, MA; Sakai, K; Uy-Yu, N, 1990
)
0.28
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (2)

ClassDescription
fluoroanilineA substituted aniline carrying an additional fluoro substituent on the benzene ring.
primary arylamineA primary amine formally derived from ammonia by replacing one hydrogen atom by an aryl group. R-NH2 where R is an aryl group.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (5)

Activation Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Chain A, LysozymeTequatrovirus T4Kd100.000056.000082.3333100.0000AID977611
Chain A, LysozymeTequatrovirus T4Kd100.000056.000082.3333100.0000AID977611
Chain A, LysozymeTequatrovirus T4Kd100.000056.000082.3333100.0000AID977611
Chain A, LysozymeTequatrovirus T4Kd100.000056.000082.3333100.0000AID977611
EndolysinTequatrovirus T4Kd100.00003.00003.00003.0000AID238123
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (4)

Assay IDTitleYearJournalArticle
AID238123Dissociation constant against T4 lysozyme mutant L99A/M102Q2005Journal of medicinal chemistry, Jun-02, Volume: 48, Issue:11
Decoys for docking.
AID342464Dissociation constant, pKa of the compound2008Journal of medicinal chemistry, Aug-14, Volume: 51, Issue:15
The many roles for fluorine in medicinal chemistry.
AID977611Experimentally measured binding affinity data (Kd) for protein-ligand complexes derived from PDB2002Journal of molecular biology, Sep-13, Volume: 322, Issue:2
A model binding site for testing scoring functions in molecular docking.
AID1811Experimentally measured binding affinity data derived from PDB2002Journal of molecular biology, Sep-13, Volume: 322, Issue:2
A model binding site for testing scoring functions in molecular docking.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (12)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's5 (41.67)18.2507
2000's3 (25.00)29.6817
2010's3 (25.00)24.3611
2020's1 (8.33)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 37.31

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index37.31 (24.57)
Research Supply Index2.64 (2.92)
Research Growth Index4.52 (4.65)
Search Engine Demand Index48.58 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (37.31)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other13 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]